Zirconium-89 labelled antibodies for imaging PD-L1 dynamics in mesothelioma in response to immunotherapy and chemotherapy

Project Details

StatusFinished
Effective start/end date3/07/231/07/24

Funding

  • Australian and New Zealand Society of Nuclear Medicine (ANZSNM): A$20,000.00